Researchers led by Chuan-Ming Xie from the Southwest Hospital of Army Medical University in Chongqing, China, demonstrated that increased levels of FBXL6 are linked to unfavorable outcomes in liver cancer patients and contribute to the spread of liver tumors in mice. Here, FBXL6 is linked to liver cancer.